TIDMTRLS
RNS Number : 9187L
Trellus Health PLC
16 September 2021
Trellus Health plc
("Trellus Health" or the "Company")
New Partnership Agreement & Licensed Clinical Team
Established with Three Senior Hires
LONDON, UK. AND NEW YORK, U.S. ( 16 September 2021). Trellus
Health plc (AIM: TRLS), which is commercialising a scientifically
validated, resilience-based, connected health solution for chronic
condition management, announces it has established a management
services organization agreement with Connected Health Medicine PC
("Connected Health"), a state licensed Professional Corporation
that will provide multidisciplinary patient care services via
telehealth. Trellus Health will provide technology and
administrative services to Connected Health.
The partnership with Trellus Health provides Connected Health
with the technology necessary to offer digitally enabled chronic
care management services through its licensed multidisciplinary
care team, utilizing the patent-pending GRITT(TM) resilience
assessment and methodology via Trellus Health's telehealth
platform, TrellusElevate(TM). --This agreement represents the first
in a series of partnerships that will enable Trellus Health's
proprietary technology platform and resilience-building methodology
to be scaled geographically for licensed clinical care coordination
and delivery across the United States.
Unlike most digital health programs that provide patient support
through unlicensed health coaches, TrellusElevate(TM) enables
patients to receive expert clinical support from Connected Health's
licensed care team, which includes a Nurse Practitioner (NP), a
Licensed Clinical Social Worker (LCSW) experienced in psychological
and social support counselling, and a Registered Dietitian
Nutritionist (RDN), who are all trained on the
scientifically-validated GRITT(TM) resilience-building methodology.
Connected Health's multidisciplinary team coordinates with the
patient's treating gastroenterologist provider to deliver
whole-person care to effectively address the physical and
behavioral health needs of people living with chronic
conditions.
Trellus Health recently appointed Andres Jimenez, MD, MSEd, MBA,
as Chief Medical Officer. Dr. Jimenez is a practicing physician
specializing in preventive medicine and behavior change. He is also
an Executive Advisor at the Cornell Johnson Graduate School of
Management and the CEO of ImplementHIT, a digital health company
whose software and curricula have impacted over a third of all US
physicians. Dr. Jimenez will work closely with Connected Health to
ensure effective training and utilization of the GRITT (TM)
methodology and TrellusElevate (TM) platform by the licensed
clinical care team.
In association with this partnership, Connected Health has hired
three senior members to its initial licensed clinical team (further
details of which can be found below). Connected Health's licensed
care team have been trained on Trellus Health's GRITT(TM)
resilience building methodology, which incorporates positive
psychology principles into all aspects of chronic condition
management.
Trellus Health's resilience-driven methodology was validated on
Inflammatory Bowel Disease (IBD) patients at the Susan and Leonard
Feinstein IBD Clinical Center at The Mount Sinai Hospital, where
Crohn's disease was first identified by Burrill B. Crohn, MD , in
1932. Trellus Health's TrellusElevate(TM) and GRITT(TM)
resilience-building methodology will initially focus on virtual
care management for chronic gastrointestinal (GI) conditions with a
high mental health burden, such as IBD.
Trellus Health co-founders, Marla Dubinsky, MD, and Laurie
Keefer, PhD, with decades of experience in IBD and
psychogastroenterology respectively, have delivered their
resilience-driven, whole-person approach and GRITT(TM) methodology
to hundreds of patients at Mount Sinai's Feinstein IBD Center over
the last five years. The co-founders will work closely with
Connected Health's licensed clinical team to utilize and scale the
GRITT(TM) methodology using the TrellusElevate(TM) virtual care
platform and connected health solution.
Dr. Keefer explains: "By personalizing care to address the
psychosocial needs of IBD patients and applying the latest
evidence-based clinical approaches in the context of their chronic
physical condition, we can help patients achieve and sustain
disease control and enjoy a significantly improved quality of
life.
"The majority of IBD patients don't have access to expert
resources or multidisciplinary care to assist them in learning how
to effectively cope with the everyday challenges of living with a
chronic incurable condition. Trellus Health's platform provides
convenient telehealth access to Connected Health's licensed
behavioral, nursing, and nutrition professionals, to enable
delivery of the integrated, patient-centered care that all chronic
patients deserve."
Monique Fayad, CEO of Trellus Health comments, "People living
with chronic conditions are often left alone to self-manage in
between doctor visits while navigating an array of procedures,
tests, medications, and worsening symptoms, which drives high rates
of anxiety, depression, and diminished quality of life. We believe
that by using the TrellusElevate(TM) platform and validated
GRITT(TM) methodology, Connected Health will deliver the first of
its kind resilience-based approach to allow the whole individual to
emerge along a pathway to recovery.
"Trellus Health's resilience-driven methodology and platform
provide patients with real-time access to licensed
multidisciplinary professionals, personalized behavioral care
plans, and digital education resources from the comfort of their
homes, which benefits their quality of life and improves their care
experience, resulting in significant cost savings for the entire
health ecosystem. The genuine compassion and extensive experience
of Connected Health's licensed multidisciplinary care team will
transform the lives of patients through education, hope, confidence
and resilience. I cannot think of a more qualified group of
individuals for us to work with in addressing the whole-person
needs of individuals with chronic conditions wherever and whenever
they need it."
Further details of the Connected Health licensed clinical
team:
Sherese Fralin, MSN, NP, has joined as Connected Health's VP of
Clinical Operations following 20 years of leadership experience in
both clinical and research environments. Prior to joining Connected
Health, Sherese was the Director of Advanced Practice Nursing at
Lenox Hill Hospital, where she educated and evaluated the
performance of 190 Nurse Practitioner staff. Sherese was recently
featured in the Netflix documentary, "Lenox Hill - Some Heroes Wear
White Coats." She is currently pursuing her PhD in nursing
education with a focus on teaching resilience to oncology nurses
and holds certifications in Reiki and Complementary and Alternative
Medicine.
Gregg Felice, LCSW-R, has joined Connected Health as a
behavioral health and Resilience Specialist. In this role, he will
assess patients and work with them to build resilience using
Trellus Health's patent-pending GRITT(TM) methodology. A
cancer-survivor and Licensed Clinical Social Worker, Gregg
previously worked as the Director of Patient and Carepartner
Advocacy at CurePSP - the foundation for prime of life
neurodegeneration. He has over 25 years of healthcare experience
prior to joining Connected Health, including management positions
at Walgreens Speciality Pharmacy and BioScrip. Gregg also worked
for 12 years as a Clinical Oncology Social Worker at the
Westchester Medical Center.
Emily Matson, MSc, RDN, CDCES, has joined as Connected Health's
Registered Dietitian. A Registered Dietitian Nutritionist and
Certified Diabetes Care and Education Specialist, Emily has
delivered nutritional counseling both in-person and via telehealth
to patients living with IBD, IBS, diabetes, hyperlipidemia,
hypertension, and provided pediatric and general wellness
counseling. Before joining Connected Health, Emily worked as the
Clinical Support Manager for Brook Health and Registered Dietitian
at Dandelion Nutrition. Outside of Connected Health, Emily works as
a diet and nutrition teaching assistant and is contributing to the
next edition of Krause's Food & the Nutrition Care Process.
The GRITT(TM) resilience assessment and personalized treatment
methodology described is based on technology developed by Mount
Sinai faculty and licensed to Trellus Health. Mount Sinai and Mount
Sinai faculty, including Marla Dubinsky, MD, and Laurie Keefer,
PhD, have a financial interest in Trellus Health. Mount Sinai has
representation on the Trellus Health Board of Directors.
For further information please contact:
Trellus Health plc www.trellushealth.com
M onique Fayad , CEO Via Walbrook PR
Julian Baines, Chairman
Singer Capital Markets (Nominated Adviser Tel: 020 7496 3000
& Broker)
Aubrey Powell / Jen Boorer /Hannah
Woodley
Walbrook PR Limited Tel: 020 7933 8780 or trellus@walbrookpr.com
Paul McManus / Sam Allen Mob: 07980 541 893 / 07502 558 258
About Trellus Health plc (www.trellushealth.com)
Trellus Health (LSE: TRLS) is a leading pioneer in
resilience-driven care and the first digital health company focused
on the intersection of chronic physical conditions and mental
health. Trellus Health's digital-first chronic care management
solution integrates convenient access to a licensed
multidisciplinary care team with a suite of tools for resilience
assessment, education and behavior modification, remote monitoring,
health maintenance and prevention. Through its TrellusElevate(TM)
connected care platform and companion App, the company enables
coordination and delivery of expert whole-person care, addressing
both clinical and behavioral health together, in context, to
improve outcomes and reduce healthcare costs for patients,
employers, and the healthcare system.
Trellus Health is commercialising the provision of digital
chronic condition management solutions for employers and health
plans that utilise the scientifically validated resilience-based
methodology and a proprietary HIPAA-compliant technology platform
called TrellusElevate(TM) to coordinate and deliver personalised
care remotely via telehealth. The Company is initially focused on
Inflammatory bowel disease ("IBD"), which includes the chronic
incurable conditions of Crohn's Disease and ulcerative colitis, but
considers its approach to have potential utility and demand across
many chronic conditions.
The TrellusElevate(TM) platform is the Company's proprietary
connected health platform that incorporates the proprietary
methodology and learnings on resilience from clinical research and
practice conducted at the Mount Sinai IBD Center for more than five
years. The proprietary methodology and resilience-driven
multidisciplinary care model have been scientifically validated to
demonstrate meaningful improvements in patient outcomes and over 85
per cent. reduction in unplanned healthcare utilisation (emergency
department visits and hospitalisations) which the directors of the
Company believe indicates the potential for significant cost
savings for healthcare payers.
The company was founded by Dr. Marla C. Dubinsky, MD and Dr.
Laurie Keefer, PhD, both with decades of combined experience in IBD
and psychogastroenterology, respectively. Trellus Health's
patent-pending GRITT(TM) resilience assessment and personalized
treatment methodology was developed and validated at the Mount
Sinai Health System to build resilience and wellness for improved
outcomes at lower cost.
Shares in Trellus Health were admitted to trading on AIM in May
2021, under the ticker TRLS. For more information on Trellus
Health, visit www.trellushealth.com .
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest
academic medical system, encompassing eight hospitals, a leading
medical school, and a vast network of ambulatory practices
throughout the greater New York region. We advance medicine and
health through unrivaled education and translational research and
discovery to deliver care that is the safest, highest - quality,
most accessible and equitable , and the best value of any health
system in the nation. The Health System includes approximately
7,300 primary and specialty care physicians; 13 free-standing
joint-venture centers; more than 410 ambulatory practices
throughout the five boroughs of New York City, Westchester, and
Long Island; and more than 30 affiliated community health centers.
The Mount Sinai Hospital is ranked in U.S. News & World
Report's "Honor Roll" of the top 20 U.S. hospitals and among the
top in the nation by specialty: No. 1 in Geriatrics and top 20 in
Cardiology/Heart Surgery, Diabetes/Endocrinology,
Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics,
Pulmonology/Lung Surgery, Urology, and Rehabilitation. Mount Sinai
Kravis Children's Hospital is ranked in U.S. News & World
Report's "Best Children's Hospitals" among the country's best in
four out of 10 pediatric specialties. New York Eye and Ear
Infirmary of Mount Sinai is ranked among the Top 20 nationally for
ophthalmology. The Icahn School of Medicine at Mount Sinai is one
of three medical schools that have earned distinction by multiple
indicators: ranked in the top 20 by U.S. News & World Report's
"Best Medical Schools," aligned with a U.S. News & World Report
"Honor Roll" Hospital, and No. 14 in the nation for National
Institutes of Health funding. Newsweek's "The World's Best Smart
Hospitals" ranks The Mount Sinai Hospital as No. 1 in New York and
top five globally, and Mount Sinai Morningside as top 20 globally,
and "The World's Best Specialized Hospitals" ranks Mount Sinai
Heart as No. 1 in New York and No. 5 globally and the Division of
Gastroenterology as No. 5 globally. For more information, visit
https://www.mountsinai.org or find Mount Sinai on Facebook ,
Twitter and YouTube .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
AGRGPUWPBUPGGQA
(END) Dow Jones Newswires
September 16, 2021 02:00 ET (06:00 GMT)
Trellus Health (LSE:TRLS)
Historical Stock Chart
From Nov 2024 to Dec 2024
Trellus Health (LSE:TRLS)
Historical Stock Chart
From Dec 2023 to Dec 2024
